GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 327 filers reported holding GW PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,084,000 | +134.6% | 5,000 | +25.0% | 0.00% | – |
Q4 2020 | $462,000 | +18.5% | 4,000 | 0.0% | 0.00% | – |
Q3 2020 | $390,000 | -20.4% | 4,000 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $490,000 | +12.6% | 4,000 | +6.2% | 0.00% | – |
Q3 2019 | $435,000 | -69.1% | 3,765 | -53.9% | 0.00% | -100.0% |
Q2 2019 | $1,408,000 | -4.9% | 8,165 | -7.0% | 0.00% | 0.0% |
Q1 2019 | $1,480,000 | +89.0% | 8,780 | +8.5% | 0.00% | 0.0% |
Q4 2018 | $783,000 | -55.1% | 8,090 | -19.8% | 0.00% | -50.0% |
Q3 2018 | $1,743,000 | +23.8% | 10,090 | 0.0% | 0.00% | +100.0% |
Q2 2018 | $1,408,000 | +23.8% | 10,090 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $1,137,000 | -14.6% | 10,090 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $1,332,000 | +30.1% | 10,090 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $1,024,000 | +1.7% | 10,090 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $1,007,000 | -18.5% | 10,090 | -1.1% | 0.00% | 0.0% |
Q1 2017 | $1,235,000 | -12.9% | 10,200 | -19.6% | 0.00% | 0.0% |
Q4 2016 | $1,418,000 | – | 12,685 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital Management, LLC | 86,069 | $18,668,000 | 8.69% |
BARDIN HILL MANAGEMENT PARTNERS LP | 170,108 | $36,897,000 | 6.84% |
HARVEST MANAGEMENT LLC | 44,100 | $9,565,000 | 5.72% |
Twin Securities, Inc. | 39,541 | $8,576,000 | 5.50% |
TIG Advisors, LLC | 572,743 | $124,228,000 | 4.67% |
ALPINE ASSOCIATES MANAGEMENT INC. | 787,500 | $170,810,000 | 4.63% |
First Trust Capital Management L.P. | 105,822 | $22,953,000 | 4.49% |
Pentwater Capital Management LP | 2,102,104 | $455,946,000 | 4.35% |
OMNI PARTNERS LLP | 403,061 | $87,424,000 | 4.31% |
SPRING CREEK CAPITAL LLC | 370,000 | $80,253,000 | 3.47% |